ArticleArchives of rheumatology2026
Latent Class Analysis to Explore Subtypes of EGPA: Focusing on Respiratory Involvement and Inflammation Markers.
Article in Archives of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimsEosinophilic granulomatosis with polyangiitis (EGPA) was regarded as a heterogeneous disease with respiratory involvement manifested in various patterns. This study aimed to explore whether subtypes with different clinical features and outcomes could be identified by latent class analysis (LCA) from the perspective of the respiratory system in patients with EGPA. MATERIALS AND
methodsPatients diagnosed with EGPA between January 2000 and December 2022 were included. The clinical data and survival of the individuals were collected. Subtypes were identified using LCA according to organ involvement and anti-neutrophil cytoplasmic antibody (ANCA) status in model 1, according to patterns of respiratory involvement, other organ involvement, ANCA status, and inflammatory markers in model 2. The characteristics and prognosis of the classes were compared.
resultsOut of the 330 patients initially diagnosed with EGPA, 245 patients were included eventually. In model 1, 138 (56.3%) and 107 (43.7%) patients were identified in classes 1 and 2, respectively. Class 2 was older (P = .017), had less musculoskeletal, mucocutaneous, cardiovascular, gastrointestinal, and peripheral nervous involvement (all P < .001) compared to class 1. No significant difference in overall survival was found between the classes. In model 2, LCA assigned 165 (67.3%) participants to class 1 (systemic EGPA) and 80 (32.7%) to class 2 (respiratory-limited EGPA). Compared with class 1, class 2 was younger (P < .001) and had lower levels of inflammation markers (white blood cell, eosinophil, erythrocyte sedimentation rate, and C-reactive protein: P < .001). Besides, patients in class 2 were more likely to have airway involvement, including the onset of asthma (P = .041), FEV1/ FVC < 70% (P < .001), and bronchiectasis (P < .001). Moreover, class 2 exhibited better survival compared to class 1 (P = .001).
conclusionThe respiratory-limited EGPA may be the relatively milder type of disease. Other organ functions, serum inflammatory markers, and ANCA should be monitored during follow-up in these patients. Cite this article as: Gu Y, Liu Y, Zhang T, Han Y, Peng M, Shi J. Latent class analysis to explore subtypes of EGPA: Focusing on respiratory involvement and inflammation markers. Arch Rheumatol. 2026;41(2):81-89.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.